Contact LinkedIn Twitter
Cabaletta Bio, Inc.
  • Home
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Our Collaborators
    • Culture & Community
  • Technology
    • CABA™ Platform
    • Posters & Publications
  • Pipeline
    • Overview
    • CABA-201
    • DSG3-CAART
    • MuSK-CAART
    • PLA2R-CAART
    • DSG3/1-CAART
  • Patients
    • Overview
    • DesCAARTes™ Phase 1 Trial
    • MusCAARTes™ Phase 1 Trial
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Governance
  • Join Our Crew
  • Contact
Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Analyst Coverage
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Quote

  • Stock Data

  • Quote
  • Charts
  • Historical Data
  • Email Alerts
  • Contacts
  • RSS News Feed
Cabaletta Bio, Inc.
  • About
  • Technology
  • Pipeline
  • Patients
  • News & Media
  • Investors
  • Join Our Crew

2929 Arch Street
Suite 600
Philadelphia, PA 19104

© 2023 Cabaletta Bio, Inc. All Rights Reserved.
Privacy Policy Disclaimer Terms of Use Sitemap

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.